| dc.contributor.author |
Bard, Jennifer S. |
|
| dc.date.accessioned |
2010-03-31T18:29:39Z |
|
| dc.date.available |
2010-03-31T18:29:39Z |
|
| dc.date.issued |
2008 |
|
| dc.identifier.citation |
ASBH Exchange (Am. Soc’y for Bioethics and Humanities, Glenview, Ill.), Spring 2008, at 6-7 |
en_US |
| dc.identifier.uri |
http://hdl.handle.net/10601/294 |
|
| dc.description.abstract |
Professor Bard analyzes the Supreme Court’s decision in Riegel v. Medtronic, 552 U.S. 312 (2008), as a way to highlight how the Supreme Court approaches the issue of preemption. |
|
| dc.language.iso |
en_US |
en_US |
| dc.relation.uri |
http://www.asbh.org/publications/pdfs/spg.pdf |
|
| dc.title |
Supreme Court’s FDA Decisions Highlights Little Understood Issue of Preemption |
en_US |
| dc.type |
Article |
en_US |